News

Ozempic has been hailed as a miracle drug in recent years. Originally developed by the Danish company Novo Nordisk to help people with type 2 diabetes, it’s since become a popular weight loss drug for off-label use. Ozempic has proved so popular that the brand name has become the catch-all term for many other similar GLP-1 drugs like Wegovy and Mounjaro. ...

Ozempic has changed the way people think about weight loss. Thanks to semaglutide injections, people have been able to shed excess body mass while also improving their blood sugar levels. It’s estimated that 12% of the American population has taken Ozempic or a similar GLP-1 drug like Wegovy, Mounjaro, or Rybelsus. While O...

On February 20, 2025, the Honorable Thomas W. Thrash Jr. of the Northern District of Georgia issued an Opinion and Order granting Plaintiff's motion for class certification in the case captioned Jancik v. WebMD LLC, Case No. 1:22-cv-00644 (N.D. Ga.).  Plaintiff alleges WebMD violated the Video Privacy Protection Act ("VPPA") by unlawfully sharing its website users' video viewing activi...

On May 7, 2024 Judge Christopher R. Cooper of the United States District Court for the District of Columbia granted final approval of the $5.4 million class action settlement in Qureshi v. American University. Bursor & Fisher filed the lawsuit in 2020 alleging that students at American University in Spring Semester 2020 were entitled to a partial refund of tu...

On April 3, 2024, Judge Brian Cogan of the United States District Court for the Eastern District of New York appointed Sarah N. Westcot to serve on the Plaintiffs' Steering Committee in In re Oral Phenylephrine Marketing and Sales Practices Litigation, MDL No. 1:23-md-3089.

The lawsuit revolves around the effica...

Class Action Complaint

Motion for Preliminary Approval

Motion for Preliminary Approval

Full Read Share